LIMITED OFFER
Save 50% on book bundles
Immediately download your ebook while waiting for your print delivery. No promo code needed.
"Cell niches” are present in several human body tissues as a dynamic microenvironment essential to modulate stem cells’ behavior in health, under injury, and in regenerative pr… Read more
LIMITED OFFER
Immediately download your ebook while waiting for your print delivery. No promo code needed.
"Cell niches” are present in several human body tissues as a dynamic microenvironment essential to modulate stem cells’ behavior in health, under injury, and in regenerative processes. The interplay between stem cells and their niche is necessary for sustaining tissues. The extracellular matrix (ECM) is the crucial component of the stem cell. It defines the architectural space, physical binding to the cell membrane, and interactions with the neighborhood cells and supports physical stress. Domains with nano or micrometric sizes define the surface and topology of the ECM, mediating cell interactions and macrophage recruitment to injured sites.
Over the last two decades, the integration of biomedicine with other engineering and biomaterial sciences promoted the development of nanotechnology and regenerative medicine toward mimicking the specialized stem cell niches to treat diseases with less invasive and efficient therapies. Innovative approaches in nanotechnology, such as targeting the immunological system, transporting drugs across blood–brain/BBB and blood–retinal barriers/BRB, directing active moiety to specific disease location/organs, encapsulation of multiple components, and promoting signalization and pathway-specific surfaces for cell interactions and growth, are indeed promising. On the other side, developments of biomaterial scaffolds to mimic the cell niches for interactions with stem cells in vitro or in vivo have tremendous potential.
The three-dimensional printing technology offers a base for a wide array of applications, for example, developing tissue constructs, mimetic organs, organoids, and organ-on-a-chip, thus avoiding the differences between animal model species and humans. Aiming closer to the natural environments, fresh autologous products from the blood, such as platelet-rich plasma (PRP), contain platelets and leukocytes, providing growth factors, cytokines, and proteins for the resident stem cells in the stages of regeneration. PRP also provides pain relief, reducing disabilities in elderly or diseased people. This book brings thought-provoking multidisciplinary topics on the diverse aspects of basic and applied sciences. The prime focus of the compilation is to understand the challenges researchers encounter in combining nanotechnology and regenerative medicine, ultimately integrating both disciplines for the benefit of the patient and offering them a ray of hope to be cured.
1. Evolution of nanotechnology in medicines
Inês Formoso, Ranjita Shegokar, Aleksandra Zielinska, Piotr Eder, Amélia M. Silva, Eliana B. Souto
2. History and evolution of regenerative medicine
Maria Helena A. Santana and Stephany C. Huber
3. Nanotechnologies to deliver drugs through the blood-brain and blood-retinal barriers
Maria C. Costa, Ranjita Shegokar, Amélia M. Silva, Eliana B. Souto
4. Thermodynamics of nanoparticle-cell interaction
Luis, Fernando Mercier Franco and Pedro de Alcântara, Pessoa Filho
5. Nanogels for drug delivery: physicochemical properties, biological behavior and in vivo applications
Tatiana N. Pashirova, Ana Beatriz Afonso, Natalia V. Terekhova, Marat I. Kamalov, Patrick Masson, Eliana B. Souto
6. The role of blood brain and blood retinal barriers in drug delivery
Bonilla-Vidal, L., Esteruelas, G., Souto, E.B., Espina M., García M. L., Sánchez-López E
7. Nanotechnology and stem cell therapy for combating COVID-19
M. Patel, R. Patel, S. Bonde, M. Rai
8. Lipid nanoparticles-based semi-solid formulations for cosmetic applications: focus on cellulite
Amélia M Silva, Ana T. Cruz, Joana Nobre, Tiago E. Coutinho, Amanda Cano, Aleksandra Zielinska, Anđelka Kovačević, Patricia Severino, Eliana B. Souto
9. 3D Bioprinting: An innovative technique for biofabrication applied to regenerative medicine and tissue engineering
M. C. Teixeira, K. K. Singh, B. A. G. De Melo, P. Severino, J. C. Cardoso, E. B. Souto
10. Stem cells, organoids, and cellular therapy
Adriana Oliveira Manfiolli, Robson Amaral, Carolina Caliari-Oliveira
11. Growth factors, cytokines, and platelet-rich plasma
Ângela Cristina Malheiros Luzo, Krissia Caroline Leme, Wagner J. Fávaro, Nelson Durán, Gabriel Gaspar Bíscaro, Alexandre Leite Rodrigues de Oliveira, Karim Boumediene, Mira Hammad, Catherine Baugé
12. The biomaterial niche of platelet-rich plasma and hyaluronic acid matrices for tissue regeneration
Bruna Alice G. de Melo, Andrea A. M. Shimojo, Carla G. França, Ângela Cristina M. Luzo, José Fabio S.D. Lana, Maria Helena A. Santana
13. Biomaterials application in wound healing management - from fundamental physiology to advanced technology
Dias-Ferreira, J., Teixeira, M.C., Severino, P., Boonme, P., Jovanovic, J., Shegokar Ranjita, Zielińska, A., Souto, E.B.
14. Nanoscaffolds and role of 3D printed surgical dressings for wound healing application
Mayank Handa, Mukesh Soni, Sarwar Beg, Rahul Shukla
15. Platelet-rich plasma in pain management
Claudia Herrera Tambelli
16. Tissue engineering in wound healing
José L. Soriano, Manuel Ríos, Elena López, María T.Garrido, Beatriz Clares, Patricia Gálvez
17. Role of neurogenesis in regenerative medicine
Dilip Waman Shingare, Kailas Kalicharan Moravkar, Jaywant Pawar, Chandrakantsing Vijaysing Pardeshi
18. Gut microbiome interventions in regenerative medicine
Heloisa Balan Assalin, Andrey dos Santos, Alexandro Barbosa de Souza, Reinaldo Gaspar Bastos
19. Applications of nanotechnology in chronic diseases and tissue regeneration
Inês Formoso, Ranjita Shegokar, Aleksandra Zielinska, Amélia M. Silva, Eliana B. Souto
20. Electrically conductive nanomaterials for advanced cardiac tissue regeneration
Patrícia Severino, Fabio Rocha Formiga, Juliana C. Cardoso, Ricardo L. C. de Albuquerque-Júnior, Marco V. Chaud, Eliana B. Souto
21. Toxicological screening of nanoparticles for biological applications: Drosophila melanogaster a model of new era
Patrícia Severino, João Dias-Ferreira, Luciana N. Andrade, Daniele M. Lima, Luciana M. de Hollanda, Classius F. da Silva, Marco Vinicius Chaud, Claudia Carbone, Amélia M. Silva, Massimo Lucarini, Alessandra Durazzo, Raffaele Capasso, Antonello Santini and Eliana B. Souto,
MS
ES
RS
Ranjita Shegokar holds a Ph.D. degree in Pharmaceutical Technology from the SNDT University, India, and has been a postdoctoral researcher in the Department of Pharmaceutics, Biopharmaceutics and NutriCosmetics at the Free University of Berlin, Germany. Currently, she serves as Chief Scientific Officer (CSO) at Capnopharm GmbH, Germany. She has authored several research articles, book chapters, and presented her research in many national/international conferences. She has filed multiple patent applications in the area of drug delivery and targeting. Besides that, she has edited many trending books in the area of pharmaceutical nanotechnology and drug delivery aspects. For her research, she has received many prestigious national and international awards among them include recently received prestigious German Innovation Award 2022. Her areas of interest include polymeric nanoparticles, nanocrystals, lipid nanoparticles (SLNs/NLCs), nanoemulsions, cancer drug targeting and the role of excipients in delivery systems. (www.ranjitas.com)